Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome
- PMID: 12854027
- DOI: 10.1076/ocii.11.1.53.15583
Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome
Abstract
Purpose: To describe the clinical manifestations of classic pars planitis (CPP) in Mexican patients. We report here the most frequent complications, medical and surgical treatment, and visual prognosis.
Material and methods: A retrospective, descriptive case series examined the clinical features, complications, and treatment (medical and surgical) of CPP patients seen at the Inflammatory Eye Disease Clinic from January 1990 to September 1999.
Results: One hundred and sixty patients met inclusion criteria for the study. Mean age at presentation was 10 years and males were more frequently affected. Both eyes were affected in 84.4% of the cases. The most frequent complaint was decreased visual acuity. Initial visual acuity (VA) ranged from no light perception to 20/20 (mean 20/50), and mean final VA was 20/30. The most frequent clinical manifestations were vitritis (99.7%), snowballs (99.3%), retinal vasculitis (89.2%), and snowbanks (63.1%). The most common complications were cystoid macular edema (63.4%) and cataract (47.5%). Periocular corticosteroids were used in 97.5% of cases, systemic corticosteroids in 68.1%, and other immunosuppressive drugs in 21.3%.
Conclusions: CPP in the Mexican population is more frequent in males and usually presents in patients less than 14 years of age. It is typically bilateral, and the most common symptom is decreased visual acuity. The most important clinical findings are located in the vitreous and retina. Cataract and cystoid macular edema are the most frequent complications. Treatment comprises periocular and systemic corticosteroids or other immunosuppressive drugs.
Similar articles
-
Analysis of clinical features and visual outcomes of pars planitis.Int Ophthalmol. 2018 Apr;38(2):727-736. doi: 10.1007/s10792-017-0526-2. Epub 2017 Apr 7. Int Ophthalmol. 2018. PMID: 28389773
-
Implications of pars planitis-associated cystoid macular edema on visual outcome and management in children.Graefes Arch Clin Exp Ophthalmol. 2020 Aug;258(8):1803-1811. doi: 10.1007/s00417-020-04696-7. Epub 2020 Apr 28. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32346784
-
Pars planitis: epidemiology, treatment, and association with multiple sclerosis.Ocul Immunol Inflamm. 2001 Jun;9(2):93-102. doi: 10.1076/ocii.9.2.93.3975. Ocul Immunol Inflamm. 2001. PMID: 11449325
-
Pediatric Pars Planitis: A Review.Ocul Immunol Inflamm. 2023 Dec;31(10):1915-1929. doi: 10.1080/09273948.2023.2279683. Epub 2023 Dec 14. Ocul Immunol Inflamm. 2023. PMID: 37976519 Review.
-
Immunopathogenic Background of Pars Planitis.Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):127-37. doi: 10.1007/s00005-015-0361-y. Epub 2015 Oct 5. Arch Immunol Ther Exp (Warsz). 2016. PMID: 26438050 Free PMC article. Review.
Cited by
-
Corneal ectasia secondary to peripheral endotheliopathy in a patient with classic pars planitis.J Ophthalmic Inflamm Infect. 2011 Jun;1(2):77-80. doi: 10.1007/s12348-010-0005-7. Epub 2010 Oct 23. J Ophthalmic Inflamm Infect. 2011. PMID: 21484170 Free PMC article.
-
Multimodal imaging in pediatric uveitis.Ther Adv Ophthalmol. 2021 Dec 6;13:25158414211059244. doi: 10.1177/25158414211059244. eCollection 2021 Jan-Dec. Ther Adv Ophthalmol. 2021. PMID: 34901748 Free PMC article. Review.
-
Pediatric uveitis: An update.Oman J Ophthalmol. 2013 Sep;6(3):140-50. doi: 10.4103/0974-620X.122267. Oman J Ophthalmol. 2013. PMID: 24379547 Free PMC article. Review.
-
Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.Clin Ophthalmol. 2019 Sep 10;13:1761-1777. doi: 10.2147/OPTH.S180580. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31571815 Free PMC article. Review.
-
Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.Curr Rheumatol Rep. 2013 Jul;15(7):341. doi: 10.1007/s11926-013-0341-3. Curr Rheumatol Rep. 2013. PMID: 23686303 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous